Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar 13 vaccination in children with acute lymphoblastic leukemia
2009-011587-11Phase 4Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Oct 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Protective anti-pneumococcal antibody response. Started Oct 2010; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2009-011587-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011587-11.